The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens

被引:43
|
作者
Sadeharju, K
Knip, M
Hiltunen, M
Åkerblom, HK
Hyöty, H
机构
[1] Univ Tampere, Dept Virol, Sch Med, FIN-33101 Tampere, Finland
[2] Tampere Univ Hosp, Dept Microbiol, Ctr Lab Med, Tampere, Finland
[3] Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland
[4] Tampere Univ Hosp, Dept Pediat, Tampere, Finland
[5] Acad Finland, Tampere, Finland
[6] JDRF Ctr Prevent Type 1 Diabet Finland, Tampere, Finland
关键词
HLA-DR; enterovirus; Type; 1; diabetes; mumps; immune response; vaccine;
D O I
10.1007/s00125-003-1157-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. Enterovirus infections are among the environmental risk factors potentially contributing to the pathogenesis of Type 1 diabetes. The aim of this study was to evaluate virus-host interaction by analysing the enterovirus antibody levels in subjects carrying different HLA-DR alleles associated with either increased or decreased risk of Type 1 diabetes. Methods. Antibodies against coxsackievirus B4 were measured to study immune responses induced by natural enterovirus infections and against poliovirus 1 to study immune responses induced by immunisation by enterovirus antigens (vaccine). Antibodies against the mumps virus were measured as a control. Study subjects included siblings of children with Type 1 diabetes taking part in the Childhood Diabetes in Finland (DiMe) Study and carrying either HLA-DR risk (DR3 and/or DR4) or protective (DR2) alleles. Results. Children with either the HLA-DR3 or HLA-DR4 allele and those with both these risk alleles had higher Coxsackie B4 antibody levels than children carrying the HLA-DR2 allele (p=0.01, p=0.01 and p=0.008, respectively). High responders (IgG levels higher than 75 percent) were also more frequent among genetically susceptible children compared to children with the protective DR2 allele (27% vs 12%) (p<0.009). The same trend was seen for poliovirus antibodies, while mumps antibody levels had a different pattern (high responders more common among DR2-positive subjects). Conclusions/interpretation. Diabetes-associated HLA-DR risk alleles were associated with a strong immune responsiveness and protective alleles with a weak responsiveness against enterovirus antigens. This phenomenon should be taken into consideration in serological case-control studies and it might play a role in virus-induced beta-cell damage.
引用
收藏
页码:1100 / 1105
页数:6
相关论文
共 50 条
  • [41] CONSTITUTIVE AND INDUCED EXPRESSION OF HLA-DR ANTIGENS
    GIACOMINI, P
    TECCE, R
    SACCHI, A
    FISHER, PB
    GAMBARI, R
    NATALI, PG
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 560 - 560
  • [42] HLA-DR ANTIGENS IN RHEUMATOID-ARTHRITIS
    WOOLEY, PH
    BATCHELOR, RJ
    ANNALS OF THE RHEUMATIC DISEASES, 1979, 38 (02) : 188 - 189
  • [43] HLA-D ANTIGENS IN A CZECH POPULATION AND THEIR ASSOCIATION WITH HLA-DR ANTIGENS
    HINZOVA, E
    IVASKOVA, E
    CUKROVA, V
    RYCHLIKOVA, M
    FOLIA BIOLOGICA, 1980, 26 (04) : 267 - 274
  • [44] HLA-DR matching and immune regulation
    Game, DS
    Lechler, RI
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (10) : 1725 - 1726
  • [45] IDIOTYPY OF MONOCLONAL-ANTIBODIES TO HLA-DR ANTIGENS AS A MEANS FOR FURTHER DEFINITION OF HLA-DR ANTIBODIES
    QUARANTA, V
    ZANETTI, M
    REISFELD, RA
    HUMAN IMMUNOLOGY, 1982, 5 (02) : 165 - 165
  • [46] ANOMALIES OF MOLECULAR EXPRESSION OF HLA-DR AND HLA-DC/DS ANTIGENS IN LEUKEMIA AND IMMUNE DEFICIENCIES
    CHARRON, DJ
    FAILLE, A
    GROSPIERRE, B
    GRISCELLI, C
    BINET, JL
    DEGOS, L
    MERLEBERAL, H
    TURMEL, P
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1984, 26 (02): : 108 - 108
  • [47] HLA-A, HLA-B AND HLA-DR ANTIGENS IN DILATED CARDIOMYOPATHY
    KOMAJDA, M
    RAFFOUX, C
    SALAME, E
    COLOMBANI, J
    GROSGOGEAT, Y
    CABROL, C
    DAUSSET, J
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1987, 80 (08): : 1233 - 1237
  • [48] HLA-DR, DQ, AND DX ALPHA-RFLPS AND THEIR ASSOCIATIONS WITH SEROLOGICALLY DEFINED HLA-DR AND HLA-DQ ANTIGENS
    AWAD, J
    NAVARRETE, C
    SACHS, JA
    FESTENSTEIN, H
    CASSELL, PG
    NIVEN, MJ
    HITMAN, G
    IMMUNOGENETICS, 1988, 27 (01) : 73 - 76
  • [49] HLA-DR ANTIGENS IN KLEINE-LEVIN SYNDROME
    VISSCHER, F
    VANDERHORST, AR
    SMIT, LME
    ANNALS OF NEUROLOGY, 1990, 28 (02) : 195 - 195
  • [50] HLA-DR ANTIGENS IN INSULIN-DEPENDENT DIABETES
    SCHOBER, E
    SCHERNTHANER, G
    MAYR, WR
    ARCHIVES OF DISEASE IN CHILDHOOD, 1981, 56 (03) : 227 - 229